Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial

202221 citationsJournal Articlegold Open Access

Authors

This trial is registered at clinicaltrials.gov under the identifier NCT04111978 . Registered 02 October 2019.

Good health and well-being

Published in: BMC Cancer

Volume 22, Issue 1, pp. 508-508

Field-Weighted Citation Impact: 3.88